MAKO Surgical originally filed to come public back in September 2007. It filed to sell up to $86.25 million in securities. Recently it had indicated a price range of $14 to $16 per share for a 5.1 million share IPO. Apparently market conditions won’t support anywhere close to that.
The new price target range for this IPO is $10 to $11 per share for this IPO. The company makes advanced devices for minimally invasive knee surgeries. It is also a revenue generating company, and frankly is in a sector that should have supported a normal IPO.
We still show that JPMorgan, Morgan Stanley, Cowen & Co. and Wachovia are the underwriters for this and the ticker will still be "MAKO" on NASDAQ.
If you have followed our IPO index here internally you will note how many withdrawals have happened in IPO’s of late.
Jon C. Ogg
February 14, 2008
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.